🟢 Bristol-Myers Squibb is trading 4.18% up today amid broader healthcare-sector strength

Bristol-Myers Squibb is trading at $61.76, up 4.18%, in line with strength across healthcare.

• The supplied sector context reports XLV up 2.12%, supported by strong earnings and outlooks from industry leaders.
• No clear company-specific catalyst explains the gain.
• On October 15, Bristol-Myers Squibb had unfavorable news that its Phase 3 Opdivo brain-cancer trial was considered unlikely to meet its overall-survival goal; reporting did not link that news to the share move.